Effects of dietary antioxidants and 2-amino-3-methylimidazo[4,5-f]- quinoline (IQ) on preneoplastic lesions and on oxidative damage, hormonal status, and detoxification capacity in the rat.
The potential beneficial or adverse affect of prolonged dietary administration of moderate to high doses (1-100 mg/kg diet) of the antioxidants, lycopene, quercetin and resveratrol or a mixture of lycopene and quercetin was investigated in male F344 rats. Selected markers for toxicity and defense mechanisms were assayed in blood, liver and colon and the impact of the antioxidant administrations on putative preneoplastic changes in liver and colon was assessed. The dietary carcinogen, 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) (200 mg/kg diet) served as a pro-oxidant, genotoxicity and general toxicity control. IQ increased the levels of protein and DNA oxidation products in plasma, the area of glutathione S-transferase-placental form positive (GST-P) foci in the liver as well as the number of colonic aberrant crypt foci (ACF). All antioxidants and the antioxidant combination significantly increased the level of lymphocytic DNA damage, to an extent comparable with the effect induced by IQ. In contrast to the control group where no GST-P foci were detected, GST-P foci were detected in animals exposed to quercetin, lycopene and the combination of the two. However, the increase in the volume of GST-P foci did not reach statistical significance. The present results indicate that moderate to high doses of common dietary antioxidants can damage lymphocyte DNA and induce low levels of preneoplastic liver lesions in experimental animals. Long-term exposure to moderate to high doses of antioxidants may thus via pro-oxidative mechanisms and non-oxidative mechanisms modulate carcinogenesis.
Breinholt
Vibeke M
VM
Institute of Food Safety and Nutrition, Danish Veterinary and Food Administration, 2860 Søborg, Denmark. vib@fdir.dk
Mølck
Anne Marie
AM
Svendsen
Gitte W
GW
Daneshvar
Bahram
B
Vinggaard
Anne M
AM
Poulsen
Morten
M
Dragsted
Lars O
LO
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D015415:Biomarkers; D002338:Carotenoids / Q000494:pharmacology; D003106:Colon / Q000473:pathology; D020552:Comet Assay; D004032:Diet; D005982:Glutathione Transferase / Q000378:metabolism; D006728:Hormones / Q000097:blood*; D007150:Immunohistochemistry; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D000077276:Lycopene; D008297:Male; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects*; D010920:Placenta / Q000187:drug effects / Q000201:enzymology; D011230:Precancerous Conditions / Q000188:drug therapy*; D011794:Quercetin / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D011916:Rats, Inbred F344; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology
D000975:Antioxidants; D015415:Biomarkers; D006728:Hormones; D011804:Quinolines; D013267:Stilbenes; C029216:2-amino-3-methylimidazo(4,5-f)quinoline; D002338:Carotenoids; D011794:Quercetin; D005982:Glutathione Transferase; D000077185:Resveratrol; D000077276:Lycopene